Clinical Trial Update: HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia [Phase 1]

View source ↗

Summary

This update confirms the completion of a Phase Ib study of HEC53856 in non-dialysis patients with renal anemia associated with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Anemia

Drugs mentioned

• HEC53856

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic Kidney Diseases, Renal Anemia | Phase 1 | Status: COMPLETED